PCSK9 and metabolic syndrome: Specially, PCSK9 was associated significantly with hypercholesterolemia or combined hyperlipidemia; apoC3 was significant in hypertriglyceridemia, hypercholesterolemia, and combined hyperlipidemia; and sdLDL-C was highlighted in all current dyslipidemias classification.